Blood test may spare heart transplant patients from painful biopsies

NCT ID NCT04707872

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a simple blood test called Prospera can detect heart transplant rejection as accurately as the current standard—a biopsy of the heart. Researchers will compare the blood test results with biopsy results and antibody levels in 300 heart transplant recipients. If the blood test works well, it could one day reduce the need for invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Prospera blood test (donor-derived cell-free DNA)
What this could lead to
If successful, this could lead to a simple blood test that reduces the need for invasive heart biopsies to check for transplant rejection.
What could go wrong
This is an early-stage study focused on calibrating the test, not proving it works in practice. The blood test may not be accurate enough to replace biopsies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Heart Failure Transplant Unit

    NOT_YET_RECRUITING

    A Coruña, Spain

  • Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute

    RECRUITING

    Dallas, Texas, 75246, United States

  • Baptist Health Institute for Research and Innovation

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute

    NOT_YET_RECRUITING

    Darlinghurst, NSW 2010, Australia

  • Cardiovascular Medicine, University of Utah Health

    RECRUITING

    Salt Lake City, Utah, 84132, United States

  • Columbia University Medical Center, Columbia Interventional Cardiovascular Care

    RECRUITING

    West New York, New Jersey, 10032, United States

  • Division of Cardiology, University of Alberta

    RECRUITING

    Edmonton, Alberta, T6G 2R7, Canada

  • Heart Failure and Heart Transplant Unit, University of Bologna

    NOT_YET_RECRUITING

    Bologna, 40138, Italy

  • Institute for Clinical and Experimental Medicine - IKEM Videnska 1958/9

    RECRUITING

    Prague, 140 21, Czechia

  • Montefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL

    RECRUITING

    The Bronx, New York, 10467, United States

  • Silesian Center for Heart Diseases (Ś!ąskie Centrum Chorób Serca w Zabrzu

    RECRUITING

    Zabrze, 41-800, Poland

  • Tampa General Hospital, 409 Bayshore Blvd.

    RECRUITING

    Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.